Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS

Author:

Gladstone Douglas E1,D'Alessio Franco2ORCID,Howard Christopher3,Lyu Mi-Ae4,Mock Jason R.5ORCID,Gibbs Kevin W.6,Abrams Darryl7ORCID,Huang Meixian4,Zeng Ke4,Herlihy James P.3,Castillo Sergio T.3,Bassett Roland8,Sadeghi Tara9,Parmar Simrit4,Flowers Christopher R.4,Mukherjee Siddhartha10,Schoenfeld David11,Thall Peter F.8,Slutsky Arthur S.12ORCID

Affiliation:

1. 1Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY

2. 2Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, MD

3. 3Department of Medicine, Baylor College of Medicine, Houston, TX

4. 4Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

5. 5Division of Pulmonary Diseases and Critical Care Medicine, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC

6. 6Section on Pulmonary, Critical Care, Allergy and Immunologic Diseases, Wake Forest School of Medicine, Winston-Salem, NC

7. 7Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Vagelos College of Physicians & Surgeons, and Center for Acute Respiratory Failure, New York-Presbyterian Hospital, New York, NY

8. 8Department of Biostatistics, MD Anderson Cancer Center, Houston, TX

9. 9Cellenkos Inc., Houston, TX

10. 10Division of Hematology/ Oncology, Department of Medicine, New York-Presbyterian Hospital, Columbia University Irving Medical Center, New York, NY

11. 11Mass General Hospital, Biostatistics, Boston, MA

12. 12Keenan Research Center, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto and University of Toronto, Toronto, Canada

Publisher

American Society of Hematology

Subject

Hematology

Reference24 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3